PhenoCycler-Fusion 2.0 Instrument
More Discoveries, Faster than Ever!
We’ve rebranded some of our products, learn more ›
CODEX® is now PhenoCycler, Phenoptics™ is now Phenolmager.
Experience the Fastest Spatial Biology Solution
In the ever-evolving landscape of spatial biology research, speed is essential to unlocking new discoveries.
PhenoCycler®-Fusion 2.0 is the fastest solution for spatial biology researchers who need to achieve the quickest route to results.
Trusted by top academic and industry leaders, this next-generation platform sets the pace for groundbreaking spatial discoveries.
How Does PhenoCycler-Fusion 2.0 Work?
PhenoCycler-Fusion 2.0 is the fastest spatial biology platform that combines automated fluidics with high-speed imaging to generate high-resolution images of multiple biomarkers on tissue sections. Here is how it works:
Iterative Cycling and Imaging
Iterative Cycling and Imaging
The platform works by staining the tissue in a single-step and iteratively cycling and imaging fluorescently labeled antibodies across the tissue through a reveal-image-remove cycle.
Oligonucleotide Barcode Technology
Oligonucleotide Barcode Technology
Each antibody is tagged with a unique oligonucleotide barcode, enabling PhenoCycler-Fusion 2.0 to seamlessly scale the number of biomarkers identified and quantified across the same tissue section.
Multi-slide automation with parallel fluidics and imaging
Multi-slide automation with parallel fluidics and imaging
By automating and parallelizing the fluidics and imaging process, PhenoCycler-Fusion 2.0 enables researchers to generate high-resolution images of multiple samples and panels simultaneously, significantly reducing the time it takes to complete experiments and accelerating the pace of discovery.
Efficient Data Management
Multi-slide automation with parallel fluidics and imaging
PhenoCycler-Fusion software produces high-resolution images while prioritizing manageable data sizes. It exclusively utilizes the preferred QPTIFF format, ensuring effortless compatibility with various software solutions for seamless spatial data analysis.
Experience Spatial Biology 2X Faster
Experience Spatial Biology 2X Faster
The combination of rapid fluidics, multi-slide automation, and parallel image processing make PhenoCycler-Fusion 2.0 the fastest spatial biology solution.
Turnaround Time
PhenoCycler-Fusion 2.0
2X Faster
Standard Platforms
More Discoveries, Faster than Ever!
Discover a new frontier in spatial phenotyping using the powerful combination of multi-slide automation and an expansive imageable area:
Effortlessly phenotype large tissue on one slide while accommodating hundreds of tissue microarrays on another.
1 Large Sample, 300 TMA Cores, Single Run
Tonsil
TMA
2 Samples Per Slide, Single Run
Skin, Lung
Skin
Seamlessly phenotype multiple small tissues types on each slide, unlocking the ability to study varied samples concurrently.
Dive into the intricacies of different tissue types by phenotyping a large tissue on each slide.
1 Large Sample Per Slide, Single Run
Head & Neck
Cerebellum
2 Panels in Parallel
Tonsil; 25 Plex Core Immune Markers
NSCLC; 25 Plex Core + Proliferation Markers
Harness the power of multi-slide automation and dual-panel analysis to elevate your research capabilities and accelerate scientific breakthroughs. This innovative approach empowers you to:
- Accelerate your research progress by addressing multiple biological questions simultaneously.
- Enhance the efficiency of your workflow by reducing the number of required runs.
- Strengthen the reliability of your results by ensuring consistency across samples.
Related Resources
Product Literature
Case Studies
Webinars
Product Literature
Case Studies
White Paper | How Spatial Phenotyping Can Uncover Novel Insights in Tissue Biology
Publication | Mapping the Spatial Proteome of Head and Neck Tumors: Key Immune Mediators and Metabolic Determinants in the Tumor Microenvironment
Ultrahigh-plex Spatial Phenotyping of Cutaneous Squamous Cell Carcinoma from Immune-competent and Immunocompromised Patients
Webinars
Spatial Phenotyping: A Revolutionary Approach to Biomarker Discovery for Cancer Immunotherapy